Moloney Securities Asset Management’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

Moloney Securities Asset Management’s Portfolio SURF Stock Details SURF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-12,250	Closed	-$8.56K	–	459
2023 Q1	$8.56K	Sell	12,250 -1,000	-8%	-$810	﹤0.01%	413
2022 Q4	$10.9K	Buy	+13,250	New	+$13.1K	﹤0.01%	384
2021 Q1	–	Sell	-10,000	Closed	-$92K	–	445
2020 Q4	$92K	Buy	+10,000	New	+$86.9K	0.02%	371

Other funds holding SURF

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

AVAI

Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

YCM

Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Moloney Securities Asset Management's SURF Position: Q2 2023 in Review

Moloney Securities Asset Management sold out of Surface Oncology, Inc. Common Stock (SURF) in Q2 2023, closing a stake of 12,250 shares — an estimated $8.56K sold.

Moloney Securities Asset Management first reported a position in SURF in Q4 2020 and held it in 3 quarters. The position peaked at $92K in Q4 2020. 61 funds tracked by Wall St. Rank hold SURF as of Q2 2023.

Moloney Securities Asset Management reported no remaining Surface Oncology, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Moloney Securities Asset Management sold 12,250 Surface Oncology, Inc. Common Stock shares in Q2 2023, an estimated $8.56K.
Moloney Securities Asset Management first reported a position in Surface Oncology, Inc. Common Stock in Q4 2020 and held it in 3 quarters.
Moloney Securities Asset Management's Surface Oncology, Inc. Common Stock position peaked at $92K in Q4 2020.
61 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q2 2023.

Based on Moloney Securities Asset Management's 13F filing for Q2 2023, filed 31 Jul 2023.